中国的药品市场正在发生根本性变化,逐渐转向创新和质量。所有药企都需要重新审视自己的产品组合、研发,尤其是原研药和创新药的营销模式。
![Headshot of BCG expert Frank Jia](https://web-assets.bcg.com/dims4/default/2d81c81/2147483647/strip/true/crop/300x300+0+0/resize/500x500!/format/webp/quality/90/?url=http%3A%2F%2Fboston-consulting-group-brightspot.s3.amazonaws.com%2F63%2Ff0%2Fbfcb70b64489a86e6494322cc163%2Ffrank-jia.png)
Education
- MBA, INSEAD
Frank Jia is a core member of Boston Consulting Group's Health Care practice in Greater China.
Frank has extensive experience in health care, and has served many local and multinational pharmaceutical and medtech companies, and health care service providers. He has helped clients with a range of key topics, including strategy development, operations, overseas expansion, organization and governance, mergers and acquisitions, and commercial strategy.